Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial



Patients undergoing coronary stenting for obstructive coronary artery disease require dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 receptor blocker, for a certain period to reduce the risk of ischemic events such as stent thrombosis.

Copyright © 2020 Terumo India Private limited

X
Important information regarding

By using this website, you consent to the use of cookies in accordance with our